Companies drawn to Blue Sky Center in Cuyama Valley
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Port of Hueneme cuts debt as revenue soars
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Dubroff: Merger underscores disruption reshaping region’s health care
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
CSUCI gets $1.2 million grant for STEM program
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Ex-CEO suing CoastHills Credit Union agrees to arbitration
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Los Osos biotech firm announces four-company merger
Four privately held biotech firms across the U.S. announced Oct. 16 that they had merged under Los Osos name Discovery Life Sciences. The deal was facilitated through an investment by Chicago-based Water Street Healthcare Partners. The merger included the Central Coast firm, Conversant Bio, Folio Bio and Phylogeny, which have operations in Columbus, Ohio and Read More →
Amgen buys $66 million stake in genetics device company
Thousand Oaks biotech giant Amgen broadened its reach into genetics research Oct. 18 with a $66 million investment in handheld DNA sequencing company Oxford Nanopore Technologies. Genetics has been a research focus for Amgen since its 2012 acquisition of deCODE, particularly in the area of Alzheimer’s therapies. The news follows closely the release by Oxford Read More →
